Brexpiprazole Impurity 86 | CAS 66490-33-3 - Request Quote
Brexpiprazole Impurity 86
| SZ CAT No: | SZ-B011107 |
| CAS No | 66490-33-3 |
| Mol.F. | C8H5ClS |
| Mol.Wt. | 168.6 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Brexpiprazole Impurity 86 is chemically 4-Chlorobenzo[b]thiophene. Brexpiprazole Impurity 86 is supplied with detailed characterization data compliant with regulatory guideline. Brexpiprazole Impurity 86 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brexpiprazole.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 66490-33-3
Purchase 66490-33-3
Order 66490-33-3
Enquire 66490-33-3
price of 66490-33-3
66490-33-3 Supplier
66490-33-3 Manufacturer
66490-33-3 Exporter
buy high quality Brexpiprazole Impurity 86
Purchase Brexpiprazole Impurity 86
Brexpiprazole Impurity 86 suppliers
Brexpiprazole Impurity 86 manufacturers
Brexpiprazole Impurity 86 price
Order Brexpiprazole Impurity 86
Enquire Brexpiprazole Impurity 86
Brexpiprazole Impurity 86 cost
Brexpiprazole Impurity 86 Supplier
Brexpiprazole Impurity 86 Distributor
Brexpiprazole Impurity 86 for Method Validation
Brexpiprazole Reference Standard
Brexpiprazole Impurity 86 for ANDA Filing
Brexpiprazole Impurity 86 for Forced Degradation Studies
Brexpiprazole Impurity 86 Identification Standards
Brexpiprazole Impurity 86 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.